|
Name |
Coleon U
|
| Molecular Formula | C20H26O5 | |
| IUPAC Name* |
(4aR)-5,6,8,10-tetrahydroxy-1,1,4a-trimethyl-7-propan-2-yl-3,4-dihydro-2H-phenanthren-9-one
|
|
| SMILES |
CC(C)C1=C(C2=C(C(=C1O)O)[C@]3(CCCC(C3=C(C2=O)O)(C)C)C)O
|
|
| InChI |
InChI=1S/C20H26O5/c1-9(2)10-13(21)11-12(16(24)14(10)22)20(5)8-6-7-19(3,4)18(20)17(25)15(11)23/h9,21-22,24-25H,6-8H2,1-5H3/t20-/m1/s1
|
|
| InChIKey |
XPYRMWZAUHBOPE-HXUWFJFHSA-N
|
|
| Synonyms |
Coleon U; 65714-69-4; NSC337582; (4aR)-5,6,8,10-tetrahydroxy-1,1,4a-trimethyl-7-propan-2-yl-3,4-dihydro-2H-phenanthren-9-one; COLEON U-ERU 702; SCHEMBL4778751; CHEMBL1986340; DTXSID50318849; ZINC24737307; AKOS004906901; NSC-337582; NCI60_002961
|
|
| CAS | 65714-69-4 | |
| PubChem CID | 333723 | |
| ChEMBL ID | CHEMBL1986340 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 346.4 | ALogp: | 5.1 |
| HBD: | 4 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 98.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 25 | QED Weighted: | 0.427 |
| Caco-2 Permeability: | -4.905 | MDCK Permeability: | 0.00001800 |
| Pgp-inhibitor: | 0.058 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.02 | 20% Bioavailability (F20%): | 0.051 |
| 30% Bioavailability (F30%): | 0.011 |
| Blood-Brain-Barrier Penetration (BBB): | 0.025 | Plasma Protein Binding (PPB): | 100.06% |
| Volume Distribution (VD): | 0.348 | Fu: | 1.43% |
| CYP1A2-inhibitor: | 0.456 | CYP1A2-substrate: | 0.88 |
| CYP2C19-inhibitor: | 0.22 | CYP2C19-substrate: | 0.475 |
| CYP2C9-inhibitor: | 0.641 | CYP2C9-substrate: | 0.738 |
| CYP2D6-inhibitor: | 0.452 | CYP2D6-substrate: | 0.194 |
| CYP3A4-inhibitor: | 0.243 | CYP3A4-substrate: | 0.233 |
| Clearance (CL): | 2.153 | Half-life (T1/2): | 0.124 |
| hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.148 |
| Drug-inuced Liver Injury (DILI): | 0.796 | AMES Toxicity: | 0.292 |
| Rat Oral Acute Toxicity: | 0.087 | Maximum Recommended Daily Dose: | 0.362 |
| Skin Sensitization: | 0.873 | Carcinogencity: | 0.07 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.877 |
| Respiratory Toxicity: | 0.919 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001116 | ![]() |
0.797 | D0WY9N | ![]() |
0.254 | ||
| ENC005919 | ![]() |
0.321 | D01CKY | ![]() |
0.241 | ||
| ENC001084 | ![]() |
0.313 | D0R6RC | ![]() |
0.228 | ||
| ENC004387 | ![]() |
0.293 | D08NQZ | ![]() |
0.221 | ||
| ENC002308 | ![]() |
0.292 | D05AFR | ![]() |
0.217 | ||
| ENC004386 | ![]() |
0.284 | D02GAC | ![]() |
0.217 | ||
| ENC004923 | ![]() |
0.274 | D08LTU | ![]() |
0.216 | ||
| ENC002307 | ![]() |
0.274 | D0J2NK | ![]() |
0.208 | ||
| ENC002036 | ![]() |
0.273 | D0N0RU | ![]() |
0.205 | ||
| ENC005237 | ![]() |
0.269 | D0T5XN | ![]() |
0.200 | ||